Showing 351 - 360 of 394
The financial crisis has led to controversial discussions about the capital base of the European insurance industry. Dividend cuts have been suggested to preserve capital. However, some observers seem to fear that investors could interpret a reduction of dividends as a sign of future problems....
Persistent link: https://www.econbiz.de/10008497785
Claims data studies are becoming an increasingly important source of information for healthcare stakeholders. The importance and scientific use of claims data of the statutory health funds has further increased. We saw a general lack of elaborated recommendations for best practices in this field...
Persistent link: https://www.econbiz.de/10010892329
Background: According to the AMNOG act, the German Federal Joint Committee (G-BA) determines the additional benefit of new medicines as a basis for subsequent price negotiations. Pharmaceutical companies may withdraw their medications from the market at any time during the process. This analysis...
Persistent link: https://www.econbiz.de/10012010779
In our article we consider insurance as a means of allocating terrorism risk. Terrorism poses a significant challenge for insurers worldwide. In terms of possible losses it fits into the same category as earthquakes and hurricanes. Yet as a result of the uncertainty surrounding these risks...
Persistent link: https://www.econbiz.de/10010276581
The pharmacy sector in many European countries continues to be subject to strict governmental regulations. This consists - depending on the country - of regulations on ownership, business operations, opening hours, personnel, pricing, prohibiting certain sales methods (e.g. mail order), and...
Persistent link: https://www.econbiz.de/10010276610
Introduction: Until recently, adjuvant treatment options for higher stage resectable cutaneous melanoma were limited. Two studies with a similar set-up, published 2017, led to registration of targeted therapy for BRAF-mutated melanoma with dabrafenib and trametinib as well as of the...
Persistent link: https://www.econbiz.de/10014489875
Background: Strokes cause an estimated annual health care burden of 170 billion euros across Europe. Atrial fibrillation is one of the major risk factors for stroke and increases the individual risk 4.2-fold. But prevention with anticoagulants may reduce this risk by 70%. Screening methods are...
Persistent link: https://www.econbiz.de/10014489892
Background: With atrial fibrillation (AF) the risk of stroke is 4.2-fold increased to a comparable population without AF. This risk decreases by up to 70% if AF is detected early enough and effective stroke preventive measures are taken as recommended by international guidelines. Long-term...
Persistent link: https://www.econbiz.de/10014489956
Persistent link: https://www.econbiz.de/10008429103
Routinedatenstudien können den Akteuren des Gesundheitswesens nützliche Informationen liefern. Infolgedessen hat die Bedeutung und wissenschaftliche Nutzung von Routinedaten der gesetzlichen Krankenversicherung in den letzten Jahren stetig an Relevanz gewonnen. Bisher liegen nur sehr...
Persistent link: https://www.econbiz.de/10010484708